U.S. Platelet Rich Plasma (prp) Market Size & Outlook

The platelet rich plasma (prp) market in the United States is expected to reach a projected revenue of US$ 493.8 million by 2030. A compound annual growth rate of 10.5% is expected of the United States platelet rich plasma (prp) market from 2024 to 2030.
Revenue, 2023 (US$M)
$245.5
Forecast, 2030 (US$M)
$493.8
CAGR, 2024 - 2030
10.5%
Report Coverage
U.S.

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. platelet rich plasma (prp) market, 2018-2030 (US$M)

U.S. platelet rich plasma (prp) market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

U.S. platelet rich plasma (prp) market highlights

  • The U.S. platelet rich plasma (prp) market generated a revenue of USD 245.5 million in 2023 and is expected to reach USD 493.8 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
  • In terms of segment, pure prp was the largest revenue generating type in 2023.
  • Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.


Platelet rich plasma (prp) market data book summary

Market revenue in 2023USD 245.5 million
Market revenue in 2030USD 493.8 million
Growth rate10.5% (CAGR from 2023 to 2030)
Largest segmentPure prp
Fastest growing segmentLeukocyte Rich PRP
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPure PRP, Leukocyte Rich PRP
Key market players worldwideJohnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences


Other key industry trends

  • In terms of revenue, U.S. accounted for 37.9% of the global platelet rich plasma (prp) market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 178.1 million by 2030.

Pure prp was the largest segment with a revenue share of 51.57% in 2023. Horizon Databook has segmented the U.S. platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. is recognized as the largest contributor to revenue generation in the global PRP market. The local presence of a large number of leading manufacturers that focus on the development of novel PRP preparation systems is expected to contribute to market growth.

High adoption of platelet-rich plasma treatments across key end-use settings, such as hospitals & clinics, and growing adoption by offices or physician clinics are expected to expand the PRP market in the U.S.

Supportive regulatory authorities are further driving the market in the country. The U.S. FDA's Center for Biologics Evaluation and Research (CBER) is the regulatory body responsible for PRP products. The CBER grants 510(k) application approval for the marketing of PRP preparation systems in the U.S. Most of the currently available PRP plasma preparation systems have 510(k) FDA clearance.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Platelet Rich Plasma (PRP) Market Companies

Name Profile # Employees HQ Website
Celling Biosciences View profile - -
APEX Biologix View profile 11-50 Murray, Utah, United States, North America https://apexbiologix.com
Juventix Regenerative Medical View profile 11-50 Tampa, Florida, United States, North America https://juventix.com/
Dr. PRP USA View profile 11-50 Stafford, Texas, United States, North America https://www.drprpusa.com
EmCyte Corporation View profile 11-50 Fort Myers, Florida, United States, North America https://emcyte.com/
Arthrex View profile 5001-10000 Naples, Florida, United States, North America https://www.arthrex.com/
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

U.S. platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)

U.S. Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)

U.S. platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online